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Abstract
Background: Eczema can have a considerable impact on quality of life.
Treatments can improve this, but management is complex. Barriers to
eczema self‐management may be impacted upon by environmental context,
such as the COVID‐19 pandemic.
Objectives: To explore experiences of eczema, self‐management, and
accessing healthcare and advice during the COVID‐19 pandemic among
young people with eczema and parents/carers of children with eczema.
Methods: Qualitative semi‐structured interviews were carried out with 36
participants recruited from general practices as part of randomised
controlled trials of online eczema resources.
Results: Changes to everyday life—Periods of staying at home due to the
pandemic alter the burden of eczema, with reports of an improved routine
and application of topical treatments for many, but difficulties with hand-
washing for others. Parents/carers reported improved eczema control due
to closures of educational settings. Young people reported higher stress
that may have triggered eczema flare‐ups.
Changes to access to advice and treatment—There was a reluctance to
seek medical appointments in a non‐emergency situation. Participants re-
ported a lack of trust in the outcome of telephone consultations because
health professionals were unable to see or feel the skin. Delays or diffi-
culties when obtaining appointments and treatments caused frustration.
Access to an online eczema resource was reported to have extra value in
the context of the pandemic.
Conclusion: Changes to lifestyle and access to healthcare during the
pandemic have affected eczema and self‐management. Healthcare settings
may want to consider providing extra reassurance around remote
consultations.
I. Muller and K. Greenwell are joint last authors.
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1 | INTRODUCTION
Eczema is a skin condition that can considerably affect
quality of life for the person with eczema and their family1
buteffective treatmentsandself‐managementofeczema
can improve this. Eczema self‐management can be
complex. Key components of self‐management are the
avoidance of triggers, such as soap, and application of
topical treatments, including regular use of emollients
and application of topical corticosteroids for flare‐ups.2
The National Institute for Health and Care Excellence
guidelines suggest that the underuse of treatments is the
main cause of treatment failures. Previous research has
identified barriers to self‐management, including limited
knowledge of eczema, concerns about eczema treat-
ments and treatments being time‐consuming.3–6
Recent evidence suggests the COVID‐19 pandemic
has had an impact on the mental health and emotional
wellbeing of young people,7,8 and there have been calls
to investigate the implications of this for chronic skin
conditions.9 We interviewed parents/carers of children
with eczema and young people with eczema during the
pandemic, and explored the impact of the pandemic on
their experience of eczema, eczema management and
seeking health care for eczema.
The current interview study was embedded in rand-
omised controlled trials of the Eczema Care Online
(ECO) digital self‐management interventions, which
began recruitment in November 2019.10 Qualitative data
collection started in March 2020, coinciding with the first
UK lockdowndue to theCOVID‐19pandemic (seeBox1)
that changed the living circumstances of many partici-
pants. Therefore, questions were added to the in-
terviews, providing a unique opportunity to examine how
the pandemic affected participants, the management of
eczema and the way in which they accessed healthcare
during the pandemic.
2 | PATIENTS AND METHODS
2.1 | Study design and data collection
The ECO research programme developed and trialled
two online behavioural interventions using theory‐, ev-
idence‐ and person‐based approaches.10–12 One is for
parents/carers of children with eczema and the second
is for young people with eczema. The interventions
aimed to reduce eczema severity by supporting self‐
management, including use of emollients and topical
corticosteroids, management of triggers, emotional/
stress management and reduced scratching.
The study design was a qualitative interview study
and was part of a mixed‐methods process evaluation
embedded in the ECO randomised controlled trials.10
Over 600 ECO trial participants were recruited via mail‐
out from 98 general practices across Wessex, West of
England, East Midlands, and Thames Valley and South
Midlands. Eligible participants included young people
aged 13 to 25 with eczema and parent/carers of chil-
dren with eczema aged 0 to 12 years. Young people
What is already known about this
topic?
� Effective eczema self‐management involves
regular application of topical treatments and
avoidance of triggers.
� People with eczema and their carers often find
eczema difficult to manage, and treatments
can be a challenge to fit into everyday life.
� Some of the barriers to eczema self‐
management, such as the time‐consuming
nature of treatments or difficulties avoiding
triggers, are affected by environmental
context.
What does this study add?
� Pandemic‐related restrictions meant some
people said they had more time for eczema
treatments and less exposure to triggers
outside the home, highlighting the context‐
specific nature of treatment burden.
� Increased handwashing triggered hand
eczema and some young people felt that
stress caused by the pandemic worsened
their eczema.
� Remote consultations were viewed as less
satisfactory than face‐to‐face consultations,
with a concern that health professionals can't
fully assess and advise on treatments.
What are the clinical implications of
this work?
� There may be value in providing advice to
minimise the impact that changes during the
pandemic may have on eczema, for instance
around handwashing.
� The emotional impact of the pandemic needs
to be acknowledged and support provided
with stress management.
� Reassurance before and/or during remote
consultations could boost patient or carer
confidence in consultation outcomes.
� Online eczema resources can provide reas-
surance when people are reluctant to seek
healthcare professionals support.
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and children had to have a confirmed diagnosis of
eczema, have obtained a prescription for eczema
treatment in the past 12 months, and have a POEM
score (measuring eczema severity)13 of greater than
five. Participants consented online, and parental con-
sent was sought for young people aged under 16.
Interviewees were purposively sampled from trial
participants who had consented to be approached for
an interview. Sampling ensured a range of ages,
ethnicity, socioeconomic status, eczema severity, inter-
vention usage, trial group (intervention and usual care)
and a balance of genders. Process evaluation interview
topics included views and experiences of the ECO
intervention, perceived changes following the interven-
tion, facilitators and barriers to use, and views on
implementation of the intervention. Additional questions
were added in March 2020 (Box 2) to evaluate how the
COVID‐19 pandemic affected participants' experiences
of eczema and its management, and the use of the ECO
interventions. A patient and public involvement (PPI)
representative (AR) reviewed and provided feedback on
the interview topic guide.
Data collection took place from 24 March 2020 to 2
February 2021. Interviews were spread out across this
time period to capture perspectives from different
stages of the ongoing pandemic. Phone interviews
were carried out due to the pandemic social distancing
rules (see Box 1), were audio‐recorded and transcribed
verbatim. The interviewing team (M.St, L.H, K.G, K.S)
were female post‐doctorate researchers and three were
involved in the development of the ECO interventions.
Interviewers wrote detailed summaries after each inter-
view and met weekly to discuss these, refining the
interview topic guides and sampling strategy
where necessary. Interviews were carried out until
meaning saturation of the process evaluation data was
reached, which was defined as being able to fully un-
derstand participants' diverse intervention experi-
ences.14 The study was approved by the South Central
Oxford A Research Ethics Committee (19/SC/0351).
2.2 | Data analysis
Data were analysed by following the six stages of Braun
and Clarke’s thematic analysis.15 M.St familiarised
herself with the transcripts and extracted all data
relating to COVID‐19. NVivo (version 12) was used to
manage the data. Using an inductive approach, line‐by‐
line coding was carried out and codes organised into
broader themes. Codes and themes were presented
and discussed with a team consisting of a general
practitioner, health researchers, and psychologists. A
PPI representative (AR) reviewed the study findings
and provided feedback on interpretations. Such a
collaborative approach aimed to develop a richer more
nuanced understanding of the data.16
3 | RESULTS
Twenty young people and 20 parents/carers took
part in the ECO process evaluation interviews.
Thirty‐four of these (15 young people, 19 parents/
carers) included data on the COVID‐19 pandemic
(Table 1). The remaining six interviews were carried
out before the questions relating to COVID‐19 were
added to the topic guide and did not include any
mention of the pandemic or lockdown, so were not
included in the analysis. The analysis team felt that
code saturation14 was reached, as no additional
codes were generated when analysing the remaining
transcripts. However, it was agreed that additional
interviews were needed to fully understand the nu-
ances of the pandemic experiences for the groups
(i.e., meaning saturation was not reached for this
group14).
Under the broad categories of ‘changes to everyday
life’ and ‘changes to access to advice and treatment’,
five key themes were identified (Figure 1).
BOX 1 Outline of the effects of the COVID‐
19 pandemic on the United Kingdom
On 26 March 2020, the UK government
enforced a lockdown due to the COVID‐19
pandemic. This resulted in a temporary, but
significant, change in circumstances for many of
the population including:
� the closure of educational settings,
� a move to home or remote working, and
� being placed on a furlough scheme where
many people were not able to work for several
months.
The public were asked to take measures to
prevent the spread of the virus such as:
� wearing facemasks in public indoor places,
� social distancing, and
� increased handwashing.
Healthcare settings had to change the way they
delivered services, with face‐to‐face appoint-
ments being replaced by remote consultations
(online or via telephone) whenever possible.
Over the course of the next year, COVID‐19
restrictions were enforced, with rules being
relaxed and tightened, dependant on the
spread of the pandemic, and was ongoing at the
time of writing this paper.
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3.1 | Changes to everyday life
Generally, both young people and parents/carers re-
ported that spending increased time at home due to the
pandemic lockdown restrictions improved their eczema
management routine and most reported increased use
of emollients. For young people, not leaving the house
as they normally would in the mornings or evenings had
facilitated their increased use of emollients.
I've had more time in the mornings to, you
know, spend time, like, putting my moistur-
iser on, rather than kind of waking up late,
skipping that bit and then just running for the
bus. YP12 (25‐year‐old, moderate eczema)
I'm not going out as much [in the evenings],
so I'm a lot more likely to remember to put it
[emollients] on at night. YP20 (20‐year‐old,
severe eczema)
Participants also said that the ease of having treat-
ments and bathing facilities close to hand when at
home also made eczema care more straightforward.
[It was] much easier, as well, if she [my
daughter] was irritated, to have medication
during the day or go and put extra cream on
during the day or go and have a quick
shower or whatever. So, in some ways,
there was more flexibility, looking after it
[eczema] at home, than if she was out and
about. PC13 (parent/carer of a 10‐year‐old,
severe eczema)
Parents/carers said that having their children at
home from school/nursery and being able to take full






Mean age (years) 18.33 38.53
Age range (years) 13–25 25–62
Child age
Mean age (years) N/A 4.72
Age range (years) N/A 0–12
Participant gender
Female N (%) 7 (46.67) 15 (78.95)
Child gender
Female N (%) N/A 9 (47.37)
Ethnic background (self‐defined)
White British N (%) 10 (66.67) 14 (73.68)
Indian N (%) 3 (20.00) 1 (5.26)
Chinese N (%) 0 2 (10.53)
African N (%) 1 (6.67) 1 (5.26)
White & Asian N (%) 1 (6.67) 0
White & Black Caribbean N (%) 0 1 (5.26)
Trial group
Intervention N (%) 14 (93.33) 17 (89.47)
Usual care N (%) 1 (6.67) 2 (10.53)
Eczema severity (defined by POEM)a
Mild N (%) 2 (13.33) 4 (21.05)
Moderate N (%) 6 (40) 10 (52.63)
Severe N (%) 7 (46.67) 5 (26.32)
Socioeconomic status (index of multiple deprivation scoreb)
Mean 7.14 6.63
Range 2–10 1–10
aMild eczema defined as POEM 6–7; Moderate eczema POEM 8–16; Severe
eczema POEM 17–28. Respondents with very mild eczema (a POEM score
of 5 or lower) were excluded from the research.
b10 is the highest socioeconomic status.
BOX 2 Subset of interview questions rele-
vant to the COVID‐19 pandemic
Q1. We're interested in how people are finding
looking after their eczema during the coronavi-
rus lockdown. Can you tell me about how your
[child's] eczema has been during this time?
a. Prompts: change in circumstances?
extra handwashing? access to creams/
medical advice? change in stress?
b. [If changed] What do you think led to
your [child's] eczema getting better/worse?
Q2. Can you tell me about anything you are
doing differently to look after your [child's]
eczema?
Q3. We understand that everyone's experi-
ences and home situations during lockdown are
very different. What aspects of lockdown have
made it more difficult for you to manage your
[child's] eczema?
Q4. What aspects of lockdown have made it
easier for you to manage your [child's] eczema?
Q5. How have you found using the ECO web-
site during lockdown?
a. Can you tell me about any information
or advice that was difficult for you to follow
during lockdown?
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control of their eczema care, rather than relying on the
school/nursery staff or the child to remember, was
helpful.
We've had the odd day where obviously a
teacherhadn't beenon topof it [eczema]and,
you know, [name of son] would come back,
having scratched himself loads during that
day, for whatever reason. So we haven't had
that [during the pandemic]. PC08 (parent/
carer of child age 2, moderate eczema)
The nurseries closed [during the pandemic]
and he [her son] was with me all the time. So
I was there to put it on him, put the emol-
lients on him, a lot more than what maybe I
would have done if he'd been at nursery.
PC19 (parent/carer of child age 2, moderate
eczema)
Due to the pandemic, participants were unable to
have close contact with people outside of their house-
holds for extended time periods. Some described that
the loss of physical contact with their support network,
such as grandparents who assisted with childcare,
made it more difficult to cope with eczema symptoms
such as sleep disturbance.
So when I've have, sort of, multiple restless
nights [due to child not sleeping because of
itching], my mum would then say, oh, bring
her round to mine for the night and you get
some sleep. So…we can't really have that
kind of outside support and I think that's
hard. PC20 (parent/carer of child age 2,
moderate eczema)
Often, entire households were at home together
more than they would have before the pandemic. Par-
ticipants described how having other people present
served as a reminder to apply creams and improved
their awareness of habits such as scratching, which can
also trigger eczema flare‐ups.
It's made me more aware of, when I'm,
because now I'm [at home with my] family
and, you know, they make me aware as
well that, you know, you shouldn't do that or
don't itch. YP07 (24‐year‐old, severe
eczema)
There was another person in the house to
actually say…have we done [son's name]
cream? And to remind me. PC06 (parent/
carer of child under 1, severe eczema)
When participants reported eczema improvements
or flare‐ups, they tended to speculate on what may have
caused these. In addition to the increased opportunity to
apply topical treatments afforded by being at home
F I GURE 1 Key themes and findings
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more, improvements were often attributed to reduced
exposure to triggers outside of the home. Soaps were
also commonly mentioned as examples of triggers.
[My son has] not been going to nursery or
anything and using different soaps and that
type of thing. So it's [eczema] been quite
well‐controlled through lockdown. PC10
(parent/carer of a 2‐year‐old, moderate
eczema)
Conversely, some participants attributed eczema
flare‐ups to irritants in their home environment including
exposure to central heating, increased washing up, and
a lack of vitamin D due to being indoors. Some partic-
ipants also reported increased scratching due to
boredom.
So obviously at home, she's [her daughter]
bored; she can get easily frustrated. So I
suppose, in that sense, yes [her eczema
has been affected], because she's not out,
having fun and being distracted, whereas at
home, she can just be at home, bored and
then when she's bored and she can just
start itching. PC20 (parent/carer of a 2‐year‐
old, moderate eczema)
Protective measures used to prevent the spread of
COVID‐19 were perceived to have worsened eczema in
both groups. One participant described skin irritation
due to wearing protective masks at work. The most
common trigger mentioned was increased handwash-
ing with soap or hand gel. Parents/carers reported that
their children's hand eczema improved in the periods of
lockdown when children were at home and, therefore,
washed their hands less.
Using hand sanitiser when you go out, as
well, not having handwashing facilities,
hand sanitiser literally will strip my eczema;
it makes my skin so bad. YP11 (23‐year‐old,
moderate eczema)
Handwashing has made a massive [differ-
ence] which, again, is worse if she's [her
daughter] out and about, because they don't
have to wash, well, I don't know [if] they
wash their hands as often home as they do
at school. PC13 (parent/carer of child age
10, severe eczema)
Young people (mainly those with severe eczema)
often referred to stress as a trigger for eczema flare‐
ups, which for most was caused by general worry and
uncertainty regarding the pandemic. Young people also
reported worries about the health of family members or
feeling stressed about situations at school/university
caused by the pandemic.
So I [have been] really quite stressed [about
an event being cancelled due to the
pandemic] and crying and just being angry
and then that stress now, over emotional
stuff, makes my eczema and my scratching
and my allergic stuff 10 times worse. YP03
(15‐year‐old, severe eczema)
Obviously I [was] really stressed…because
we didn't really know what was happening
[with university] or anything like that. YP05
(19‐year‐old, severe eczema)
There was no mention of stress in children. When
asked, parents/carers did not think that the pandemic
had caused stress in their children.
3.2 | Changes to access to eczema
advice and treatments
A common perception among both groups was that GP
appointments would be difficult to obtain during the
pandemic or that they should not try to obtain a non‐
emergency appointment. Some participants cited a
lack of communication from their general practice as a
reason for this perception. Participants reported feeling
cut off from NHS services and taking extra measures to
ensure that their skin, or their child's skin, did not get
worse.
There wasn't really…much coming from the
doctor's side of things as to, you can still ring
us with this type of problem; we will do our
best to sort of help you. I kind of felt like we
were just, almost, like, abandoned and told
just get on with it and see how it goes, sort of
thing. PC06 (parent/carer of 11 month old,
severe eczema)
I just keep running in out of her [her
daughter] room, checking her, make sure
she's not scratching, make sure she's not
make it [eczema] worse, because now, if it
does get that bad, I mean I'm sure I can take
her to the doctor but that's in the back of
your mind, I don't know if I can, can I? Can I
just take her? It's not as easy as it was
before. So you have to really make sure it
doesn't get that bad. PC20 (parent/carer of
a 2‐year‐old, moderate eczema)
Most participants who voiced doubts about being
able to obtain medical appointments had not attempted
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or needed to do so. Only a few reported experiencing
such difficulties.
So I phoned up the GP…this morning, and I
was number 22 in the queue and I just
can't…wait…number 22, it just takes
forever and I've got, I couldn't wait. PC19
(parent/carer of a 2‐year‐old, moderate
eczema)
Some parents/carers of very young children
explained that their regular in‐person contact with the
health visitor had been replaced by telephone calls.
No one has actually seen her [my daughter]
in a very long time, physically, like in person.
So…we are kind of very much on our own in
terms of assessing how her eczema is
and … other problems. PC18 (parent/carer
of an 1‐year‐old, moderate eczema)
Participants in both groups expressed concerns
about the telephone consultations that replaced face‐
to‐face consultations during the pandemic, with many
displaying a lack of confidence in the accuracy of pre-
scriptions for treatments or the diagnosis of eczema‐
related problems such as infections. They explained
that the doctor being unable to touch or see the skin in
person was the reason for this, despite the option to
send photographs in.
Before [the pandemic], the GP can see and
touch the skin; that may be more accurate,
but after the lockdown, we only sent the
picture [of their child's eczema to the GP]
PC12 (parent/carer of a 4‐year‐old, severe
eczema)
Well I guess it's like they [health pro-
fessionals] can't feel it [eczema] them-
selves…I've taken her [her daughter] on
numerous appointments about her skin and
they sort of feel, like, examine it, feel it for
themselves, have a good look, whereas this
one, it's just a picture. There's lighting to
take into consideration; it looks different on
a picture. PC20 (parent/carer of a 2‐year‐old
moderate eczema)
In particular, when the doctor prescribed the same
treatment as they had previously been given, or a ste-
roid that they deemed to be too mild, participants
perceived this to be due to their inability to diagnose the
problem accurately and perhaps the doctor being
reluctant to prescribe a stronger treatment without
seeing the skin in person.
I think it was harder for them to, it wasn't
really harder, because they couldn't see the
skin, they didn't know what [treatment] to
accurately give us; they just gave us a refill
of the ointment that I was using. YP04
(14‐year‐old, moderate eczema)
Because of COVID it's not easy [to] get to
the GP or whatever; they've not really
looked at it [eczema]. So they only prescribe
the hydrocortisone cream. PC16 (parent/
carer of an 1‐year‐old, moderate eczema)
Even when participants were prescribed treatments
that cleared up the skin, they were still not confident in
the accuracy of remote consultations.
Some participants reported that treatments and
other products were harder to obtain. Participants
reported shortages of eczema‐friendly hand cleaning
products, long queues at pharmacies, and delays in
treatments arriving at pharmacies. Some young
people experienced delays because of registering
with a different general practice due to relocating
home from university.
Most participant reports of obtaining repeat pre-
scriptions from their general practice were positive. This
was usually due to automated or online systems. In
contrast, other participants found that obtaining repeat
prescriptions was difficult and expressed frustration at
the process used by their general practice. Although no
participants reported adverse effects from the delays in
treatment, some had almost run out of some treatment
due to these delays.
Ringing the doctors, it's just a nightmare
because of COVID. But I don't know why
they can't just let me have a repeat pre-
scription and just pop into the pharmacy and
get some more. PC19 (parent/carer of a 2‐
year‐old, moderate eczema)
[We] haven't ever completely run out of the
hydrocortisone, but we have had days when
we been having to search around for any,
almost, empty tubes, because we've been
delayed with getting the prescription. PC17
(parent/carer of a 6‐year‐old, moderate
eczema)
3.3 | Accessing online support
There were varied experiences of accessing online
support during lockdown. Some participants in the trial
intervention group found that they were too busy to
use the ECO intervention, and some who had more
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time at home thought that the pandemic had
decreased their usage of the intervention due to worry
or preoccupation.
I think I was just going out of my mind during
lockdown and, in all honesty, the [ECO]
website, it was at the back of my mind at the
time. YP18 (14‐year‐old, severe eczema)
Some participants said they had more time to look at
information about eczema online. A few parents of older
children described using their child's increased time at
home to involve the child in their own eczema care and
using the ECO website.
I think I looked at it [ECO website] more in
lockdown than I did when I'm at school.
YP17 (13‐year‐old, moderate eczema)
Because he's [her son] been at home a lot in
lockdown…we sat down and had a discus-
sion about it [ECO website] and then I
showed him the video the What Is Eczema
video. PC03 (parent/carer of a 4‐year‐old,
mild eczema)
Several participants described thinking of the ECO
website as an alternative source of eczema advice and
information to consulting with medical professionals.
This was particularly useful and reassuring to those
who were unsure about whether they would be able to
obtain healthcare professional advice during the
pandemic.
Perhaps if I'd have joined the study a little bit
earlier and had the [ECO] website a bit
earlier in lockdown, I might have used it a bit
more, thinking obviously I can't…contact the
healthcare professionals…because of the
coronavirus, then maybe I would have used
it a little bit more at the start. PC06 (parent/
carer of 11 month old, severe eczema)
4 | DISCUSSION
4.1 | Summary of findings
Both parents/carers of children with eczema and young
people with eczema noticed changes in eczema due to
reduced exposure to irritants and triggers outside of the
home during the pandemic and increased handwashing
as a protective measure against COVID‐19. Young
people noted how increased stress or worry caused
directly or indirectly by the pandemic led to a worsening
of eczema. Participants reported changes to seeking
healthcare and advice relating to eczema during the
pandemic. A reluctance to contact general practices for
non‐emergency treatment and uncertainty about the
availability of healthcare professional advice was re-
ported, leading to feelings of worry about being ‘aban-
doned’ to manage the eczema alone in some cases.
Remote consultations were commonly viewed as less
satisfactory than face‐to‐face consultations, with a
concern that if health professionals were unable to see
and feel the skin they could not assess it properly, even
when photographs were provided.
4.2 | Findings in the context of existing
research
The reported improvements to routine and increased
use of treatments due to the removal of barriers to
eczema self‐management during periods of staying at
home highlight the hidden burden of self‐managing
eczema and the importance of environmental fac-
tors.17–19 There is a need for high quality consistent
information and advice about eczema.18,20,21 Eczema
has a considerable psychosocial impact,18,22 particu-
larly amongst young people,23 and families of children
with eczema often need to rely on others for support
with eczema care.22,24 All of these are affected by
living through a pandemic, as formal healthcare can
be harder to access, stresses can be increased and
support networks are disrupted. Our findings relating
to the added stress and worry for young people due
to disruption to everyday life and to education are
similar to themes found in other qualitative work
exploring the experiences of young people during the
pandemic.7,8
During the pandemic, dermatology departments and
primary care services were advised to carry out most
appointments remotely,25,26 although this is not
welcome to all patient groups and that remote consul-
tations include risks, both to the therapeutic relationship
and also to the nature of the assessment.25 Younger
people can be more likely to welcome remote assess-
ment for its convenience,27 yet our findings suggest
that, at least for some younger parents of children with
eczema or young people with eczema, this is not the
case.
4.3 | Strengths and limitations
This study adds to the limited evidence‐base on the
impact of global pandemic conditions on people's ex-
periences of eczema and eczema management. Data
were taken from a process evaluation study where
exploring COVID‐19 experiences was not the primary
aim, however it adds to a limited literature examining
the impact of the pandemic on eczema patients and
their carers. Participants were recruited from a trial
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sample who are likely to be highly motivated to engage
with research and eczema treatments and may not be
representative of the wider eczema population.28
However, the large trial sample size meant that we
were able to sample participants with diverse
demographics.
4.4 | Implications for research, policy
and practice
Barriers to accessing treatments can be mitigated by
implementing accessible online or automated systems
in general practices that would save time and effort for
both patients and surgery staff. Further research into
the reasons behind reluctance to contact healthcare
professionals during the pandemic is needed. People
may benefit from clear guidance and reassurances,
where possible, on access to healthcare in a pandemic
situation.
Findings showed the value of a comprehensive
trusted resource for eczema advice and support such
as the ECO intervention that is easily accessible at any
time, particularly in the context of a pandemic. It was
reassuring to know that the ECO intervention was
available, even by those who did not have a need to
use it over the course of the trial. Young people needed
stress management or emotional support, which could
be readily provided within online resources, although
others may need in‐person support.
Findings relating to telephone consultations high-
light the importance of providing information before,
during and after about the process and effectiveness of
remote assessment. This can include guidance for
patients/carers about taking photos, what to expect
around the technology and the consultation, and reas-
surance from healthcare professionals that they are
confident in diagnosis and management of the condi-
tion, if appropriate, based on the verbal description and/
or photographs provided by the patient. Future
research may wish to explore the impact that face‐to‐
face or video consultation might have on reassuring
the patient and how this can be enhanced.
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